nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0484	0.469	CbGpPWpGaD
Methyldopa—DDC—blood plasma—systemic lupus erythematosus	0.0254	0.123	CbGeAlD
Methyldopa—COMT—blood plasma—systemic lupus erythematosus	0.0168	0.0815	CbGeAlD
Methyldopa—DDC—nephron tubule—systemic lupus erythematosus	0.0131	0.0635	CbGeAlD
Methyldopa—DDC—kidney—systemic lupus erythematosus	0.0115	0.0558	CbGeAlD
Methyldopa—DDC—cortex of kidney—systemic lupus erythematosus	0.0112	0.0544	CbGeAlD
Methyldopa—SLC15A1—nephron tubule—systemic lupus erythematosus	0.00973	0.0472	CbGeAlD
Methyldopa—COMT—nephron tubule—systemic lupus erythematosus	0.00865	0.042	CbGeAlD
Methyldopa—SLC15A1—kidney—systemic lupus erythematosus	0.00855	0.0415	CbGeAlD
Methyldopa—ADRA2A—blood plasma—systemic lupus erythematosus	0.00854	0.0415	CbGeAlD
Methyldopa—DDC—lung—systemic lupus erythematosus	0.00815	0.0396	CbGeAlD
Methyldopa—COMT—skin of body—systemic lupus erythematosus	0.00807	0.0392	CbGeAlD
Methyldopa—COMT—kidney—systemic lupus erythematosus	0.0076	0.0369	CbGeAlD
Methyldopa—DDC—nervous system—systemic lupus erythematosus	0.00755	0.0366	CbGeAlD
Methyldopa—COMT—cortex of kidney—systemic lupus erythematosus	0.00741	0.036	CbGeAlD
Methyldopa—DDC—central nervous system—systemic lupus erythematosus	0.00726	0.0353	CbGeAlD
Methyldopa—DDC—Parkinsons Disease Pathway—UBE2L3—systemic lupus erythematosus	0.00695	0.0674	CbGpPWpGaD
Methyldopa—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00652	0.0632	CbGpPWpGaD
Methyldopa—COMT—tendon—systemic lupus erythematosus	0.00614	0.0298	CbGeAlD
Methyldopa—COMT—bone marrow—systemic lupus erythematosus	0.00595	0.0289	CbGeAlD
Methyldopa—COMT—lung—systemic lupus erythematosus	0.00539	0.0262	CbGeAlD
Methyldopa—COMT—nervous system—systemic lupus erythematosus	0.00499	0.0242	CbGeAlD
Methyldopa—COMT—central nervous system—systemic lupus erythematosus	0.0048	0.0233	CbGeAlD
Methyldopa—ADRA2A—connective tissue—systemic lupus erythematosus	0.00455	0.0221	CbGeAlD
Methyldopa—Mesalazine—PPARG—systemic lupus erythematosus	0.004	0.405	CrCbGaD
Methyldopa—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00384	0.0372	CbGpPWpGaD
Methyldopa—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.00377	0.0183	CbGeAlD
Methyldopa—ADRA2A—tendon—systemic lupus erythematosus	0.00313	0.0152	CbGeAlD
Methyldopa—ADRA2A—lung—systemic lupus erythematosus	0.00274	0.0133	CbGeAlD
Methyldopa—ADRA2A—nervous system—systemic lupus erythematosus	0.00254	0.0123	CbGeAlD
Methyldopa—ADRA2A—central nervous system—systemic lupus erythematosus	0.00245	0.0119	CbGeAlD
Methyldopa—COMT—Phase II conjugation—NAT2—systemic lupus erythematosus	0.00228	0.0221	CbGpPWpGaD
Methyldopa—Aminosalicylic Acid—PTGS2—systemic lupus erythematosus	0.00215	0.218	CrCbGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—C4B—systemic lupus erythematosus	0.00214	0.0208	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—C4A—systemic lupus erythematosus	0.00214	0.0208	CbGpPWpGaD
Methyldopa—Epinephrine—TNF—systemic lupus erythematosus	0.00205	0.207	CrCbGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.00171	0.0166	CbGpPWpGaD
Methyldopa—Mesalazine—PTGS2—systemic lupus erythematosus	0.00169	0.171	CrCbGaD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—CSK—systemic lupus erythematosus	0.00161	0.0157	CbGpPWpGaD
Methyldopa—Skin disorder—Leflunomide—systemic lupus erythematosus	0.00147	0.00216	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.00146	0.00214	CcSEcCtD
Methyldopa—Angiopathy—Mycophenolate mofetil—systemic lupus erythematosus	0.00146	0.00214	CcSEcCtD
Methyldopa—Mediastinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00145	0.00212	CcSEcCtD
Methyldopa—Mental disorder—Cyclosporine—systemic lupus erythematosus	0.00144	0.00212	CcSEcCtD
Methyldopa—Connective tissue disorder—Hydrocortisone—systemic lupus erythematosus	0.00144	0.00211	CcSEcCtD
Methyldopa—Weight increased—Dexamethasone—systemic lupus erythematosus	0.00142	0.00208	CcSEcCtD
Methyldopa—Weight increased—Betamethasone—systemic lupus erythematosus	0.00142	0.00208	CcSEcCtD
Methyldopa—Flatulence—Cyclosporine—systemic lupus erythematosus	0.00141	0.00207	CcSEcCtD
Methyldopa—Mental disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00141	0.00206	CcSEcCtD
Methyldopa—Bradycardia—Triamcinolone—systemic lupus erythematosus	0.0014	0.00206	CcSEcCtD
Methyldopa—Bradycardia—Methylprednisolone—systemic lupus erythematosus	0.0014	0.00205	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.00138	0.00203	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.00138	0.00203	CcSEcCtD
Methyldopa—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.00138	0.00202	CcSEcCtD
Methyldopa—Abdominal distension—Prednisone—systemic lupus erythematosus	0.00137	0.00201	CcSEcCtD
Methyldopa—Paraesthesia—Leflunomide—systemic lupus erythematosus	0.00136	0.002	CcSEcCtD
Methyldopa—Connective tissue disorder—Methylprednisolone—systemic lupus erythematosus	0.00135	0.00198	CcSEcCtD
Methyldopa—COMT—Biological oxidations—NAT2—systemic lupus erythematosus	0.00133	0.0129	CbGpPWpGaD
Methyldopa—Pancreatitis—Prednisone—systemic lupus erythematosus	0.00133	0.00196	CcSEcCtD
Methyldopa—COMT—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.00131	0.0128	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.00131	0.00192	CcSEcCtD
Methyldopa—Constipation—Leflunomide—systemic lupus erythematosus	0.00129	0.0019	CcSEcCtD
Methyldopa—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.00128	0.00188	CcSEcCtD
Methyldopa—Mental disorder—Hydrocortisone—systemic lupus erythematosus	0.00128	0.00188	CcSEcCtD
Methyldopa—Cardiac disorder—Methylprednisolone—systemic lupus erythematosus	0.00127	0.00187	CcSEcCtD
Methyldopa—Bradycardia—Dexamethasone—systemic lupus erythematosus	0.00127	0.00187	CcSEcCtD
Methyldopa—Bradycardia—Betamethasone—systemic lupus erythematosus	0.00127	0.00187	CcSEcCtD
Methyldopa—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.00127	0.00186	CcSEcCtD
Methyldopa—Erectile dysfunction—Prednisone—systemic lupus erythematosus	0.00125	0.00184	CcSEcCtD
Methyldopa—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00125	0.00184	CcSEcCtD
Methyldopa—Angiopathy—Methylprednisolone—systemic lupus erythematosus	0.00125	0.00183	CcSEcCtD
Methyldopa—Mediastinal disorder—Methylprednisolone—systemic lupus erythematosus	0.00124	0.00182	CcSEcCtD
Methyldopa—Weight increased—Prednisone—systemic lupus erythematosus	0.00124	0.00182	CcSEcCtD
Methyldopa—DDC—Dopaminergic Neurogenesis—TGFB1—systemic lupus erythematosus	0.00122	0.0119	CbGpPWpGaD
Methyldopa—Myalgia—Cyclosporine—systemic lupus erythematosus	0.00122	0.00179	CcSEcCtD
Methyldopa—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.00122	0.00179	CcSEcCtD
Methyldopa—Liver function test abnormal—Methotrexate—systemic lupus erythematosus	0.00121	0.00178	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—systemic lupus erythematosus	0.00121	0.00178	CcSEcCtD
Methyldopa—Mental disorder—Methylprednisolone—systemic lupus erythematosus	0.0012	0.00177	CcSEcCtD
Methyldopa—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.0012	0.00176	CcSEcCtD
Methyldopa—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00119	0.00175	CcSEcCtD
Methyldopa—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00119	0.00175	CcSEcCtD
Methyldopa—Breast disorder—Methotrexate—systemic lupus erythematosus	0.00119	0.00174	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Methotrexate—systemic lupus erythematosus	0.00118	0.00174	CcSEcCtD
Methyldopa—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.00118	0.00173	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic lupus erythematosus	0.00118	0.00173	CcSEcCtD
Methyldopa—Oedema—Cyclosporine—systemic lupus erythematosus	0.00117	0.00172	CcSEcCtD
Methyldopa—Infection—Cyclosporine—systemic lupus erythematosus	0.00116	0.0017	CcSEcCtD
Methyldopa—Nervous system disorder—Cyclosporine—systemic lupus erythematosus	0.00115	0.00168	CcSEcCtD
Methyldopa—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.00114	0.00168	CcSEcCtD
Methyldopa—Oedema—Mycophenolate mofetil—systemic lupus erythematosus	0.00114	0.00167	CcSEcCtD
Methyldopa—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.00114	0.00167	CcSEcCtD
Methyldopa—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.00113	0.00166	CcSEcCtD
Methyldopa—Angiopathy—Betamethasone—systemic lupus erythematosus	0.00113	0.00166	CcSEcCtD
Methyldopa—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.00113	0.00166	CcSEcCtD
Methyldopa—Eosinophilia—Methotrexate—systemic lupus erythematosus	0.00112	0.00165	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL1RN—systemic lupus erythematosus	0.00112	0.0109	CbGpPWpGaD
Methyldopa—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00112	0.00164	CcSEcCtD
Methyldopa—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.00112	0.00164	CcSEcCtD
Methyldopa—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00112	0.00164	CcSEcCtD
Methyldopa—Pancreatitis—Methotrexate—systemic lupus erythematosus	0.00111	0.00163	CcSEcCtD
Methyldopa—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.00111	0.00163	CcSEcCtD
Methyldopa—Bradycardia—Prednisone—systemic lupus erythematosus	0.00111	0.00163	CcSEcCtD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—RASGRP1—systemic lupus erythematosus	0.0011	0.0107	CbGpPWpGaD
Methyldopa—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.0011	0.00161	CcSEcCtD
Methyldopa—Asthenia—Leflunomide—systemic lupus erythematosus	0.00109	0.00159	CcSEcCtD
Methyldopa—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.00108	0.00159	CcSEcCtD
Methyldopa—Pancytopenia—Methotrexate—systemic lupus erythematosus	0.00108	0.00158	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.00108	0.00158	CcSEcCtD
Methyldopa—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.00107	0.00157	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.00106	0.00156	CcSEcCtD
Methyldopa—Oedema—Prednisolone—systemic lupus erythematosus	0.00106	0.00156	CcSEcCtD
Methyldopa—Dizziness—Azathioprine—systemic lupus erythematosus	0.00106	0.00156	CcSEcCtD
Methyldopa—Paraesthesia—Cyclosporine—systemic lupus erythematosus	0.00105	0.00154	CcSEcCtD
Methyldopa—Erectile dysfunction—Methotrexate—systemic lupus erythematosus	0.00105	0.00154	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.00104	0.00152	CcSEcCtD
Methyldopa—Oedema—Hydrocortisone—systemic lupus erythematosus	0.00104	0.00152	CcSEcCtD
Methyldopa—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.00104	0.00152	CcSEcCtD
Methyldopa—Infection—Hydrocortisone—systemic lupus erythematosus	0.00103	0.00151	CcSEcCtD
Methyldopa—Paraesthesia—Mycophenolate mofetil—systemic lupus erythematosus	0.00102	0.0015	CcSEcCtD
Methyldopa—Myalgia—Triamcinolone—systemic lupus erythematosus	0.00102	0.0015	CcSEcCtD
Methyldopa—Vomiting—Azathioprine—systemic lupus erythematosus	0.00102	0.0015	CcSEcCtD
Methyldopa—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.00102	0.0015	CcSEcCtD
Methyldopa—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.00102	0.00149	CcSEcCtD
Methyldopa—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.00102	0.00149	CcSEcCtD
Methyldopa—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.00101	0.00149	CcSEcCtD
Methyldopa—Infestation—Methotrexate—systemic lupus erythematosus	0.00101	0.00149	CcSEcCtD
Methyldopa—Rash—Azathioprine—systemic lupus erythematosus	0.00101	0.00148	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.00101	0.00148	CcSEcCtD
Methyldopa—Dermatitis—Azathioprine—systemic lupus erythematosus	0.00101	0.00148	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.00101	0.00148	CcSEcCtD
Methyldopa—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.00101	0.00148	CcSEcCtD
Methyldopa—Headache—Azathioprine—systemic lupus erythematosus	0.001	0.00147	CcSEcCtD
Methyldopa—Dizziness—Leflunomide—systemic lupus erythematosus	0.001	0.00147	CcSEcCtD
Methyldopa—Constipation—Cyclosporine—systemic lupus erythematosus	0.000999	0.00147	CcSEcCtD
Methyldopa—Angiopathy—Prednisone—systemic lupus erythematosus	0.000987	0.00145	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000984	0.00144	CcSEcCtD
Methyldopa—Oedema—Triamcinolone—systemic lupus erythematosus	0.000978	0.00144	CcSEcCtD
Methyldopa—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000975	0.00143	CcSEcCtD
Methyldopa—Infection—Triamcinolone—systemic lupus erythematosus	0.000972	0.00143	CcSEcCtD
Methyldopa—Infection—Methylprednisolone—systemic lupus erythematosus	0.000969	0.00142	CcSEcCtD
Methyldopa—Vomiting—Leflunomide—systemic lupus erythematosus	0.000963	0.00141	CcSEcCtD
Methyldopa—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000958	0.00141	CcSEcCtD
Methyldopa—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000957	0.0014	CcSEcCtD
Methyldopa—Paraesthesia—Prednisolone—systemic lupus erythematosus	0.000955	0.0014	CcSEcCtD
Methyldopa—Rash—Leflunomide—systemic lupus erythematosus	0.000955	0.0014	CcSEcCtD
Methyldopa—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000954	0.0014	CcSEcCtD
Methyldopa—Mental disorder—Prednisone—systemic lupus erythematosus	0.000953	0.0014	CcSEcCtD
Methyldopa—Nausea—Azathioprine—systemic lupus erythematosus	0.000952	0.0014	CcSEcCtD
Methyldopa—Headache—Leflunomide—systemic lupus erythematosus	0.000949	0.00139	CcSEcCtD
Methyldopa—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000948	0.00139	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000946	0.00139	CcSEcCtD
Methyldopa—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000945	0.00139	CcSEcCtD
Methyldopa—Paraesthesia—Hydrocortisone—systemic lupus erythematosus	0.000933	0.00137	CcSEcCtD
Methyldopa—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000926	0.00136	CcSEcCtD
Methyldopa—Myalgia—Betamethasone—systemic lupus erythematosus	0.000926	0.00136	CcSEcCtD
Methyldopa—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000924	0.00136	CcSEcCtD
Methyldopa—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000909	0.00133	CcSEcCtD
Methyldopa—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000901	0.00132	CcSEcCtD
Methyldopa—Nausea—Leflunomide—systemic lupus erythematosus	0.000899	0.00132	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000897	0.00132	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000891	0.00131	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000889	0.00131	CcSEcCtD
Methyldopa—Oedema—Dexamethasone—systemic lupus erythematosus	0.000887	0.0013	CcSEcCtD
Methyldopa—Oedema—Betamethasone—systemic lupus erythematosus	0.000887	0.0013	CcSEcCtD
Methyldopa—Infection—Betamethasone—systemic lupus erythematosus	0.000881	0.00129	CcSEcCtD
Methyldopa—Infection—Dexamethasone—systemic lupus erythematosus	0.000881	0.00129	CcSEcCtD
Methyldopa—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000878	0.00129	CcSEcCtD
Methyldopa—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000876	0.00129	CcSEcCtD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000871	0.00845	CbGpPWpGaD
Methyldopa—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.00087	0.00128	CcSEcCtD
Methyldopa—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.00087	0.00128	CcSEcCtD
Methyldopa—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000869	0.00128	CcSEcCtD
Methyldopa—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000869	0.00128	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—ADIPOQ—systemic lupus erythematosus	0.000867	0.00841	CbGpPWpGaD
Methyldopa—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000861	0.00126	CcSEcCtD
Methyldopa—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000844	0.00124	CcSEcCtD
Methyldopa—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.00084	0.00123	CcSEcCtD
Methyldopa—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000838	0.00123	CcSEcCtD
Methyldopa—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000825	0.00121	CcSEcCtD
Methyldopa—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000821	0.00121	CcSEcCtD
Methyldopa—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000819	0.0012	CcSEcCtD
Methyldopa—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000818	0.0012	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000808	0.00119	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000808	0.00119	CcSEcCtD
Methyldopa—Arthralgia—Prednisone—systemic lupus erythematosus	0.000806	0.00118	CcSEcCtD
Methyldopa—Myalgia—Prednisone—systemic lupus erythematosus	0.000806	0.00118	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL10—systemic lupus erythematosus	0.000802	0.00778	CbGpPWpGaD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000801	0.00118	CcSEcCtD
Methyldopa—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.0008	0.00117	CcSEcCtD
Methyldopa—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000797	0.00117	CcSEcCtD
Methyldopa—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000797	0.00117	CcSEcCtD
Methyldopa—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000796	0.00117	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000783	0.00115	CcSEcCtD
Methyldopa—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.00078	0.00115	CcSEcCtD
Methyldopa—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000773	0.00113	CcSEcCtD
Methyldopa—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000773	0.00113	CcSEcCtD
Methyldopa—Oedema—Prednisone—systemic lupus erythematosus	0.000773	0.00113	CcSEcCtD
Methyldopa—Infection—Prednisone—systemic lupus erythematosus	0.000768	0.00113	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000766	0.00112	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000766	0.00112	CcSEcCtD
Methyldopa—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000765	0.00112	CcSEcCtD
Methyldopa—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000758	0.00111	CcSEcCtD
Methyldopa—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000754	0.00111	CcSEcCtD
Methyldopa—Skin disorder—Prednisone—systemic lupus erythematosus	0.000751	0.0011	CcSEcCtD
Methyldopa—COMT—Biological oxidations—RXRA—systemic lupus erythematosus	0.000747	0.00725	CbGpPWpGaD
Methyldopa—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000745	0.00109	CcSEcCtD
Methyldopa—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000743	0.00109	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—NR3C1—systemic lupus erythematosus	0.000742	0.0072	CbGpPWpGaD
Methyldopa—Rash—Cyclosporine—systemic lupus erythematosus	0.000737	0.00108	CcSEcCtD
Methyldopa—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000736	0.00108	CcSEcCtD
Methyldopa—Headache—Cyclosporine—systemic lupus erythematosus	0.000732	0.00107	CcSEcCtD
Methyldopa—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000725	0.00106	CcSEcCtD
Methyldopa—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00072	0.00106	CcSEcCtD
Methyldopa—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000719	0.00106	CcSEcCtD
Methyldopa—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000719	0.00106	CcSEcCtD
Methyldopa—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000718	0.00105	CcSEcCtD
Methyldopa—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000714	0.00105	CcSEcCtD
Methyldopa—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000711	0.00104	CcSEcCtD
Methyldopa—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000708	0.00104	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000704	0.00103	CcSEcCtD
Methyldopa—Dizziness—Prednisolone—systemic lupus erythematosus	0.000703	0.00103	CcSEcCtD
Methyldopa—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000702	0.00103	CcSEcCtD
Methyldopa—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000701	0.00103	CcSEcCtD
Methyldopa—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000701	0.00103	CcSEcCtD
Methyldopa—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.0007	0.00103	CcSEcCtD
Methyldopa—Nausea—Cyclosporine—systemic lupus erythematosus	0.000694	0.00102	CcSEcCtD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—F2—systemic lupus erythematosus	0.000694	0.00673	CbGpPWpGaD
Methyldopa—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000694	0.00102	CcSEcCtD
Methyldopa—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000687	0.00101	CcSEcCtD
Methyldopa—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000677	0.000994	CcSEcCtD
Methyldopa—Myalgia—Methotrexate—systemic lupus erythematosus	0.000674	0.000989	CcSEcCtD
Methyldopa—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000674	0.000989	CcSEcCtD
Methyldopa—Rash—Prednisolone—systemic lupus erythematosus	0.00067	0.000984	CcSEcCtD
Methyldopa—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00067	0.000983	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000669	0.000982	CcSEcCtD
Methyldopa—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000668	0.00098	CcSEcCtD
Methyldopa—Headache—Prednisolone—systemic lupus erythematosus	0.000666	0.000978	CcSEcCtD
Methyldopa—Constipation—Prednisone—systemic lupus erythematosus	0.000661	0.00097	CcSEcCtD
Methyldopa—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00066	0.000969	CcSEcCtD
Methyldopa—Rash—Hydrocortisone—systemic lupus erythematosus	0.000655	0.000961	CcSEcCtD
Methyldopa—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000654	0.00096	CcSEcCtD
Methyldopa—Headache—Hydrocortisone—systemic lupus erythematosus	0.000651	0.000955	CcSEcCtD
Methyldopa—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000647	0.000949	CcSEcCtD
Methyldopa—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000645	0.000947	CcSEcCtD
Methyldopa—Infection—Methotrexate—systemic lupus erythematosus	0.000642	0.000942	CcSEcCtD
Methyldopa—Asthenia—Betamethasone—systemic lupus erythematosus	0.000637	0.000935	CcSEcCtD
Methyldopa—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000637	0.000935	CcSEcCtD
Methyldopa—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000633	0.00093	CcSEcCtD
Methyldopa—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000632	0.000928	CcSEcCtD
Methyldopa—Nausea—Prednisolone—systemic lupus erythematosus	0.000632	0.000927	CcSEcCtD
Methyldopa—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000627	0.000921	CcSEcCtD
Methyldopa—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000622	0.000913	CcSEcCtD
Methyldopa—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00062	0.000911	CcSEcCtD
Methyldopa—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000617	0.000906	CcSEcCtD
Methyldopa—Rash—Triamcinolone—systemic lupus erythematosus	0.000617	0.000905	CcSEcCtD
Methyldopa—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000616	0.000904	CcSEcCtD
Methyldopa—Rash—Methylprednisolone—systemic lupus erythematosus	0.000615	0.000903	CcSEcCtD
Methyldopa—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000615	0.000902	CcSEcCtD
Methyldopa—Headache—Triamcinolone—systemic lupus erythematosus	0.000613	0.000899	CcSEcCtD
Methyldopa—Headache—Methylprednisolone—systemic lupus erythematosus	0.000611	0.000897	CcSEcCtD
Methyldopa—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000611	0.000897	CcSEcCtD
Methyldopa—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000607	0.000891	CcSEcCtD
Methyldopa—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000607	0.000891	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000588	0.000864	CcSEcCtD
Methyldopa—Dizziness—Betamethasone—systemic lupus erythematosus	0.000587	0.000861	CcSEcCtD
Methyldopa—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000587	0.000861	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—FAS—systemic lupus erythematosus	0.000587	0.00569	CbGpPWpGaD
Methyldopa—Nausea—Triamcinolone—systemic lupus erythematosus	0.000581	0.000853	CcSEcCtD
Methyldopa—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.00058	0.000851	CcSEcCtD
Methyldopa—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00058	0.000851	CcSEcCtD
Methyldopa—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000569	0.000836	CcSEcCtD
Methyldopa—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000564	0.000828	CcSEcCtD
Methyldopa—Vomiting—Betamethasone—systemic lupus erythematosus	0.000564	0.000828	CcSEcCtD
Methyldopa—Rash—Dexamethasone—systemic lupus erythematosus	0.000559	0.000821	CcSEcCtD
Methyldopa—Rash—Betamethasone—systemic lupus erythematosus	0.000559	0.000821	CcSEcCtD
Methyldopa—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000559	0.000821	CcSEcCtD
Methyldopa—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000559	0.000821	CcSEcCtD
Methyldopa—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000558	0.000819	CcSEcCtD
Methyldopa—Headache—Betamethasone—systemic lupus erythematosus	0.000556	0.000816	CcSEcCtD
Methyldopa—Headache—Dexamethasone—systemic lupus erythematosus	0.000556	0.000816	CcSEcCtD
Methyldopa—Asthenia—Prednisone—systemic lupus erythematosus	0.000554	0.000814	CcSEcCtD
Methyldopa—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000529	0.000776	CcSEcCtD
Methyldopa—Nausea—Betamethasone—systemic lupus erythematosus	0.000527	0.000774	CcSEcCtD
Methyldopa—Nausea—Dexamethasone—systemic lupus erythematosus	0.000527	0.000774	CcSEcCtD
Methyldopa—Dizziness—Prednisone—systemic lupus erythematosus	0.000511	0.00075	CcSEcCtD
Methyldopa—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000511	0.000749	CcSEcCtD
Methyldopa—Vomiting—Prednisone—systemic lupus erythematosus	0.000491	0.000721	CcSEcCtD
Methyldopa—Rash—Prednisone—systemic lupus erythematosus	0.000487	0.000715	CcSEcCtD
Methyldopa—Dermatitis—Prednisone—systemic lupus erythematosus	0.000487	0.000715	CcSEcCtD
Methyldopa—Headache—Prednisone—systemic lupus erythematosus	0.000484	0.000711	CcSEcCtD
Methyldopa—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000476	0.000699	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—PPARG—systemic lupus erythematosus	0.000469	0.00455	CbGpPWpGaD
Methyldopa—Asthenia—Methotrexate—systemic lupus erythematosus	0.000463	0.00068	CcSEcCtD
Methyldopa—Nausea—Prednisone—systemic lupus erythematosus	0.000459	0.000674	CcSEcCtD
Methyldopa—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000442	0.000649	CcSEcCtD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—CLU—systemic lupus erythematosus	0.000433	0.00421	CbGpPWpGaD
Methyldopa—Dizziness—Methotrexate—systemic lupus erythematosus	0.000427	0.000627	CcSEcCtD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—P2RY12—systemic lupus erythematosus	0.00042	0.00407	CbGpPWpGaD
Methyldopa—Vomiting—Methotrexate—systemic lupus erythematosus	0.000411	0.000603	CcSEcCtD
Methyldopa—Rash—Methotrexate—systemic lupus erythematosus	0.000407	0.000598	CcSEcCtD
Methyldopa—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000407	0.000597	CcSEcCtD
Methyldopa—Headache—Methotrexate—systemic lupus erythematosus	0.000405	0.000594	CcSEcCtD
Methyldopa—ADRA2A—G alpha (i) signalling events—P2RY12—systemic lupus erythematosus	0.0004	0.00388	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—CSK—systemic lupus erythematosus	0.000386	0.00375	CbGpPWpGaD
Methyldopa—Nausea—Methotrexate—systemic lupus erythematosus	0.000384	0.000563	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—EP300—systemic lupus erythematosus	0.000376	0.00365	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.000371	0.0036	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—VEGFA—systemic lupus erythematosus	0.000356	0.00345	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—LYN—systemic lupus erythematosus	0.000351	0.00341	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000318	0.00308	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—EP300—systemic lupus erythematosus	0.000307	0.00298	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—TNF—systemic lupus erythematosus	0.000305	0.00296	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CXCL12—systemic lupus erythematosus	0.000269	0.00261	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	0.000263	0.00256	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NAT2—systemic lupus erythematosus	0.000257	0.00249	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITGAX—systemic lupus erythematosus	0.000251	0.00243	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000248	0.0024	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—F3—systemic lupus erythematosus	0.000247	0.0024	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—systemic lupus erythematosus	0.000246	0.00239	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000242	0.00235	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NAT2—systemic lupus erythematosus	0.000228	0.00221	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CLU—systemic lupus erythematosus	0.000223	0.00217	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000222	0.00215	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—P2RY12—systemic lupus erythematosus	0.000216	0.0021	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000214	0.00207	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	0.000204	0.00198	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—systemic lupus erythematosus	0.000201	0.00195	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SELE—systemic lupus erythematosus	0.000199	0.00193	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—CSK—systemic lupus erythematosus	0.000199	0.00193	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	0.000191	0.00185	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITGAM—systemic lupus erythematosus	0.000187	0.00182	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CCR5—systemic lupus erythematosus	0.000184	0.00179	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—LYN—systemic lupus erythematosus	0.000181	0.00176	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—C3—systemic lupus erythematosus	0.00018	0.00175	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SH2B3—systemic lupus erythematosus	0.000177	0.00172	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000171	0.00166	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	0.000166	0.00161	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000163	0.00158	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000147	0.00142	CbGpPWpGaD
Methyldopa—DDC—Metabolism—RXRA—systemic lupus erythematosus	0.000144	0.0014	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000143	0.00139	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IFNA1—systemic lupus erythematosus	0.000139	0.00135	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ALB—systemic lupus erythematosus	0.000138	0.00134	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000137	0.00133	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000136	0.00132	CbGpPWpGaD
Methyldopa—COMT—Metabolism—RXRA—systemic lupus erythematosus	0.000128	0.00124	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	0.000126	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000126	0.00122	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000124	0.0012	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000112	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	0.000112	0.00109	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000112	0.00108	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—C3—systemic lupus erythematosus	0.000109	0.00106	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—JAK1—systemic lupus erythematosus	0.000105	0.00102	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2RA—systemic lupus erythematosus	9.83e-05	0.000954	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—F2—systemic lupus erythematosus	9.57e-05	0.000929	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	9.51e-05	0.000922	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.2e-05	0.000893	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PPARG—systemic lupus erythematosus	9.09e-05	0.000882	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NAT2—systemic lupus erythematosus	9.06e-05	0.000879	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	8.73e-05	0.000847	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	8.58e-05	0.000833	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—F2—systemic lupus erythematosus	8.56e-05	0.000831	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCL2—systemic lupus erythematosus	8.53e-05	0.000828	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.36e-05	0.000811	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALB—systemic lupus erythematosus	8.17e-05	0.000793	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PPARG—systemic lupus erythematosus	8.07e-05	0.000783	CbGpPWpGaD
Methyldopa—DDC—Metabolism—NOS3—systemic lupus erythematosus	7.81e-05	0.000758	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.79e-05	0.000756	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TLR9—systemic lupus erythematosus	7.57e-05	0.000735	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.34e-05	0.000712	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALB—systemic lupus erythematosus	7.25e-05	0.000704	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—systemic lupus erythematosus	7.15e-05	0.000693	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ALB—systemic lupus erythematosus	7.11e-05	0.00069	CbGpPWpGaD
Methyldopa—COMT—Metabolism—NOS3—systemic lupus erythematosus	6.94e-05	0.000673	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	6.93e-05	0.000672	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS3—systemic lupus erythematosus	6.8e-05	0.00066	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CSK—systemic lupus erythematosus	6.75e-05	0.000655	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.66e-05	0.000646	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—systemic lupus erythematosus	6.35e-05	0.000616	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.31e-05	0.000612	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.22e-05	0.000603	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NCF2—systemic lupus erythematosus	6.17e-05	0.000599	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—C3—systemic lupus erythematosus	6.16e-05	0.000598	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LYN—systemic lupus erythematosus	6.13e-05	0.000595	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.04e-05	0.000586	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SH2B3—systemic lupus erythematosus	6.02e-05	0.000584	CbGpPWpGaD
Methyldopa—DDC—Metabolism—EP300—systemic lupus erythematosus	5.94e-05	0.000577	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2—systemic lupus erythematosus	5.77e-05	0.000559	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.73e-05	0.000556	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.64e-05	0.000548	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—C3—systemic lupus erythematosus	5.6e-05	0.000543	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—F2—systemic lupus erythematosus	5.41e-05	0.000525	CbGpPWpGaD
Methyldopa—COMT—Metabolism—EP300—systemic lupus erythematosus	5.28e-05	0.000512	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—EP300—systemic lupus erythematosus	5.17e-05	0.000502	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—RXRA—systemic lupus erythematosus	5.08e-05	0.000493	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.94e-05	0.000479	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—F2—systemic lupus erythematosus	4.91e-05	0.000477	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—VEGFA—systemic lupus erythematosus	4.9e-05	0.000475	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—JUNB—systemic lupus erythematosus	4.84e-05	0.00047	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.6e-05	0.000447	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TGFB1—systemic lupus erythematosus	4.5e-05	0.000436	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRL—systemic lupus erythematosus	4.46e-05	0.000433	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.38e-05	0.000425	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.98e-05	0.000386	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.64e-05	0.000354	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—JAK1—systemic lupus erythematosus	3.57e-05	0.000346	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCR5—systemic lupus erythematosus	3.38e-05	0.000328	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.33e-05	0.000323	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2—systemic lupus erythematosus	3.31e-05	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—C3—systemic lupus erythematosus	3.31e-05	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PPARG—systemic lupus erythematosus	3.21e-05	0.000311	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	2.9e-05	0.000282	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	2.88e-05	0.00028	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	2.78e-05	0.00027	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	2.76e-05	0.000268	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	2.59e-05	0.000251	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	2.52e-05	0.000245	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	2.35e-05	0.000228	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	2.31e-05	0.000224	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	2.1e-05	0.000204	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2e-05	0.000194	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	1.95e-05	0.00019	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	1.94e-05	0.000189	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	1.85e-05	0.000179	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.84e-05	0.000179	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	1.75e-05	0.00017	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.66e-05	0.000161	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.52e-05	0.000148	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	1.15e-05	0.000111	CbGpPWpGaD
